How should I manage an acute severe vertigo episode with suspected vestibular migraine and inner‑ear inflammation in a patient who has frequent epistaxis, heavy menstrual bleeding, and a history of unsuccessful migraine prophylaxis?

Management of Acute Severe Vertigo with Suspected Vestibular Migraine

This patient requires immediate initiation of migraine prophylaxis given the severe, disabling vestibular migraine episode with strong family history and documented migraine pattern—specifically, start the prescribed candesartan that has been sitting unused since September, as this addresses both the acute vestibular symptoms and prevents future episodes that are clearly impacting quality of life and work capacity.

Acute Episode Management

The severe vertigo episode with nausea/vomiting, bilateral nystagmus, and negative Dix-Hallpike testing strongly suggests vestibular migraine rather than BPPV 1, 2. The temporal relationship to menses (cycle day 23, with onset 3 days before period) and strong family history further support this diagnosis 3.

Immediate Treatment Considerations

• Dexamethasone: The prescribed dexamethasone has limited evidence for vestibular migraine and is more appropriate for acute unilateral vestibulopathy. Given the patient's concerns about side effects and the diagnosis being more consistent with vestibular migraine, this can be deferred 4.

• Acute symptom control: For severe nausea/vomiting during acute episodes, use nonoral triptans with antiemetics 5. This is critical given the severity of symptoms that prevented head movement for 6 hours.

• Rescue therapy: Establish a triptan + NSAID combination for future acute episodes, starting treatment immediately at symptom onset 5, 1.

Prophylactic Management (Priority)

The patient needs prophylaxis immediately—the severity of this episode (unable to work for over a week, falling out of bed, requiring multiple ER visits) demands preventive treatment 2, 3.

First-Line Prophylaxis

Start candesartan now. This medication was appropriately prescribed in September but never taken. The patient's previous intolerance to beta-blockers (orthostatic dizziness) makes candesartan an excellent choice, as it's effective for migraine prevention without the same orthostatic side effect profile 1, 6.

Why Not Other Options First

• Beta-blockers: Already failed due to orthostatic dizziness
• Valproate/anticonvulsants: Patient declined previously; also concerning given heavy menstrual bleeding (valproate can worsen bleeding)
• Tricyclic antidepressants: Not yet trialed but can be second-line if candesartan fails 1, 6
• Supplements (Migranol, Bacopa, Curcumin): These were helping with migraine frequency before discontinuation—consider restarting after establishing pharmaceutical prophylaxis

Addressing Comorbid Concerns

Heavy Menstrual Bleeding and Epistaxis

The combination of frequent epistaxis (severe episode night before vertigo), heavy menstrual clotting, and increased menstrual bleeding over the past year raises concern for:

• Possible bleeding disorder: Check CBC, iron studies, PT/PTT, von Willebrand panel
• Hormonal influence on migraine: The vestibular migraine episode occurring on cycle day 23 (late luteal phase) suggests hormonal triggering 3
• Avoid NSAIDs if bleeding disorder confirmed: This would necessitate relying more heavily on acetaminophen and triptans for acute treatment 5

Critical pitfall: Do not dismiss the epistaxis-vertigo temporal relationship. Severe epistaxis the night before could indicate a vascular event, coagulopathy, or shared pathophysiology. The CT performed in one ER should be reviewed for any vascular abnormalities 7.

Medication Overuse Headache Risk

The patient was using Migranol twice daily as maintenance—this is concerning for potential medication overuse. Threshold for medication overuse headache is ≥10 days per month for triptans 5. The current 1.5-week headache-free period post-vertigo (after stopping all supplements) may represent withdrawal improvement.

Diagnostic Clarification

The three different diagnoses (BPPV, vestibular migraine mixed with BPPV, inner ear inflammation) reflect diagnostic confusion. The correct diagnosis is vestibular migraine based on:

• Negative Dix-Hallpike testing (three times) rules out BPPV 1
• Bilateral nystagmus (not typical for peripheral vestibular disorders) 4
• Strong migraine history with family history 3
• Temporal relationship to menses 3
• Associated migrainous features (photophobia implied by "white flickering," coordination issues) 1
• Duration of symptoms (6 hours of severe vertigo fits vestibular migraine) 8, 9

Vestibular migraine is the most common cause of spontaneous episodic vertigo after BPPV 8, 1, and this patient's presentation is classic.

Lifestyle Modifications (Essential Component)

While establishing pharmacologic prophylaxis 5:

• Hydration: Critical given nausea/vomiting during episodes
• Regular sleep schedule: Particularly important around menses
• Identify triggers: The "dizziness triggered by chewing crunchy food" suggests trigeminal nerve involvement—avoid hard/crunchy foods during vulnerable periods
• Stress management: Return to work scheduled soon; establish workplace accommodations if needed
• Regular meals: Prevent hypoglycemia as trigger

Follow-Up Plan

1. Week 1-2: Start candesartan, recheck bleeding parameters
2. Week 4: Assess candesartan efficacy and tolerability; consider reintroducing supplements if pharmaceutical prophylaxis established
3. Month 3: If inadequate response, add tricyclic antidepressant or consider CGRP antagonist (though latter is expensive) 2, 3
4. Ongoing: Track vestibular symptoms and headaches separately; monitor for medication overuse pattern

Key Pitfalls to Avoid

• Do not treat as BPPV: Epley maneuvers are ineffective and may worsen symptoms in vestibular migraine
• Do not delay prophylaxis: This episode caused significant disability; waiting for another episode is unacceptable
• Do not ignore bleeding history: This needs concurrent evaluation
• Do not restart supplements without pharmaceutical prophylaxis: The severity of this episode demands evidence-based preventive medication first 2

The patient's anxiety about dexamethasone side effects suggests health anxiety—address this directly when prescribing candesartan to ensure compliance. The fact that candesartan has been sitting unused for months is the most modifiable risk factor for preventing future disabling episodes.